Data as of Oct 28, 2026.

vsCompare their flowsaskIQ about these two fundsAsk the committee about these two funds
Across categories

TLT vs XBI: Differences, Returns & Fees

Share
Share on XDownload as PDF

Over the year to Oct 28, 2026, TLT returned −7.9% to XBI's +41.2%, and TLT charges 0.15% to XBI's 0.35%.

askIQ about this page

askIQ about TLT and XBI

Net assets on Oct 27, 2026: $47.4bn for iShares 20+ Year Treasury Bond ETF and $10.3bn for State Street SPDR S&P Biotech ETF.

At a glance
−7.9%
TLT total return, 1 year
+41.2%
XBI total return, 1 year
0.15%
TLT expense ratio
0.35%
XBI expense ratio

Pair scorecard

TLT costs 0.20 points a year less; their one-year returns differ by 49.1 points; TLT is 4.6 times larger.

TLT vs XBI: Differences, Returns & Fees
MeasureTLTXBI
Return
Total return, 1 year−7.9%+41.2%
Drawdown
Below its high42.6%, high on Aug 4, 2020
Below its all-time high8.9%, high on Feb 8, 2021
Benchmark
What it tracksICE U.S. Treasury 20+ Year Bond IndexBiotech
Cost and size
Expense ratio0.15%0.35%
Net assets, as of Oct 27, 2026$47.4bn$10.3bn
Active share vs the S&P 50098%
Holdings
Holdings in common0%
In the S&P 500, by weight13%
Top ten holdings, share of the fund18%

Holdings in common uses holdings dated Oct 27, 2026. Method

Risk and return

Feb 17, 2006 to Oct 23, 2026 · 1,079 weekly returns
TLT XBI
Return
Total return edge XBI +73.9% +817.9%
Annualized edge XBI +2.7% +11.3%
Price return edge XBI −10.6% +767.9%
Risk
Volatility edge TLT 13.9% 29.2%
Max drawdown edge TLT −47.8% −61.5%
Risk-adjusted
Sharpe edge XBI 0.14 0.45
Sortino edge XBI 0.19 0.66
Calmar edge XBI 0.06 0.18
Reading

XBI returned more: +817.9% to +73.9%. TLT swung less: 13.9% to 29.2%. TLT fell less at its worst: −47.8% to −61.5%.

Full scorecard

9 measures, with how each is measured
Open ↓
Risk and return: TLT vs XBI: Differences, Returns & Fees
MeasureTLTXBIEdgeHow it is measured
Return
Total return+73.9%+817.9%XBIPrice change plus distributions, reinvested.
Annualized+2.7%+11.3%XBITotal return as a yearly rate.
Price return−10.6%+767.9%XBIPrice change alone, distributions left out.
Risk
Volatility13.9%29.2%TLTSpread of weekly returns, annualized. Lower is steadier.
Downside deviation9.8%20.0%TLTLike volatility, counting only weeks below the Treasury bill rate.
Max drawdown−47.8%−61.5%TLTDeepest fall from a high to the low after it.
Risk-adjusted
Sharpe0.140.45XBIReturn above Treasury bills per unit of volatility.
Sortino0.190.66XBIReturn above Treasury bills per unit of downside deviation.
Calmar0.060.18XBIAnnualized return divided by the max drawdown.

Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 1,079 weekly returns. Cash rate: the 13-week Treasury bill.

What they share

0%

By the books each fund has filed, TLT and XBI hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.

0 half 100%

half

0% in common

Positions both hold · largest shared weight first TLT XBI
Only in one fund ↓
Only in TLT
TREASURY BOND 4.32%
TREASURY BOND 4.12%
TREASURY BOND (OLD) 4.07%
TREASURY BOND 4.02%
TREASURY BOND 3.93%
TREASURY BOND 3.92%
TREASURY BOND 3.89%
TREASURY BOND 3.88%
Only in XBI
MODERNA INC 2.24%
TWIST BIOSCIENCE CORP 1.86%
NATERA INC 1.82%
BIOGEN INC 1.75%
HALOZYME THERAPEUTICS INC 1.75%
UNITED THERAPEUTICS CORP 1.71%
AMGEN INC 1.68%
ABBVIE INC 1.67%
Check overlap with more funds →

Side by side

TLT iShares 20+ Year Treasury Bond ETF XBI State Street SPDR S&P Biotech ETF
Where it sits Bond ETF Thematic ETF
What it is Tracks an index of 20+ year Treasuries Biotech
Total return, 1 year −7.9% +41.2%
Its benchmark over the same days −7.8% (BBLB) not measured
Gap to its benchmark −0.1 pts vs BBLB not measured
Expense ratio 0.15% 0.35%
Holdings 47 165
Net assets, as of Oct 27, 2026 $47.4bn $10.3bn

TLT and XBI on the fields both publish, as of Oct 28, 2026. Source: ETFIQ.

Client brief · page 1 of 2 Report BR-1533F5138D

TLT and XBI do different jobs. What does each one do in a portfolio?

  1. What each follows. TLT follows ICE U.S. Treasury 20+ Year Bond Index and XBI follows Biotech.
  2. Holdings in common. 0% of the weight is in the same securities (holdings dated Oct 27, 2026).
  3. One-year total return. Over 1 year to Oct 28, 2026 TLT returned −7.9% and XBI +41.2% with distributions reinvested, a gap of 49.1 points.

Data as of Oct 28, 2026.

The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.

Your saved page · Privacy.

Alert

TLT and XBI flows, by email on Sundays.

One-click unsubscribe. See Privacy.

About each fund
TLT

TLT tracks an index of 20+ year Treasuries. Over the year to Oct 28, 2026 it returned −7.9% with distributions reinvested, against −7.8% for its benchmark, the ICE U.S. Treasury 20+ Year Bond Index. The prospectus expense ratio is 0.15% a year. It sat 42.6% below its high of Aug 4, 2020 on Oct 28, 2026.

XBI

By weight, 13% of XBI's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 18% of the fund across 165 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +41.2% with distributions reinvested. It sits 8.9% below its all-time high of Feb 8, 2021.

Questions people ask

Are TLT and XBI in the same category?
TLT is a bond ETF and XBI is a thematic ETF, so they do different jobs. The table compares what both publish: return, cost and holdings.
Which returned more over the last year, TLT or XBI?
In the year to Oct 28, 2026, with distributions reinvested, TLT returned −7.9% and XBI +41.2%.
Which is cheaper, TLT or XBI?
TLT is cheaper, by 0.20 percentage points a year. That is about $20 on $10,000 held for a year. Fees come from each fund's prospectus.
Other comparisons
Cite this pageCitation, APA and Markdown

ETFIQ, TLT against XBI, data as of Oct 28, 2026. https://etfiq.com/compare/any/tlt-vs-xbi

Open data →

Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.